Mylan is expanding its voluntary nationwide recall to the hospital/user level of select lots of Gemcitabine for Injection and Methotrexate Injection due to the presence of visible foreign particulate matter observed during testing of retention samples. Please see the StayAlert published on May 28, 2015 to review the initial recall notice. Follow the link below to review the newly added recalled lot numbers.
Sign Up For A Free 30-Day Trial of StayAlert >>
